Brainsway
- Country
- 🇮🇱Israel
- Ownership
- -
- Employees
- 106
- Market Cap
- -
- Introduction
Brainsway Ltd. engages in the development and sale of non-invasive neurostimulation treatments using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD). The Deep TMS uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
Clinical Trials
20
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2024-04-10
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- Brainsway
- Target Recruit Count
- 104
- Registration Number
- NCT06357832
- Locations
- 🇺🇸
Novus Neurology, Tuscaloosa, Alabama, United States
🇺🇸Inland Psychiatric Medical Group, Inc., Redlands, California, United States
🇺🇸DTMS Center LLC, Palm Beach, Florida, United States
Evaluation of the Long Term Efficacy and Durability of the BrainsWay Deep TMS in OCD Subjects
- Conditions
- Obsessive-Compulsive Disorder
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- Brainsway
- Target Recruit Count
- 124
- Registration Number
- NCT05404360
Brainsway DTMS for Treatment of MDD Using iTBS
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2020-12-23
- Lead Sponsor
- Brainsway
- Target Recruit Count
- 177
- Registration Number
- NCT04679753
- Locations
- 🇨🇦
SynapseTMS, Yorkton, Saskatchewan, Canada
Combining H1-Coil Deep Transcranial Magnetic Stimulation (dTMS) and App-guided CBT in Subjects With Major Depression Disorder (MDD)
- Conditions
- Data Collection for Facilitation of Machine Learning Algorithm for Personalized Treatment
- First Posted Date
- 2020-07-02
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Brainsway
- Target Recruit Count
- 540
- Registration Number
- NCT04455646
- Locations
- 🇺🇸
Kadima Neuropsychiatry, San Diego, California, United States
🇺🇸Advanced Mental Health Care Inc. - Juno Beach, Juno Beach, Florida, United States
🇺🇸Advanced Mental Health Care Inc. - Palm Beach, Palm Beach, Florida, United States
Efficacy of H7-Coil DTMS Compared to H1-Coil DTMS in Subjects With Major Depression Disorder (MDD)
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- Brainsway
- Target Recruit Count
- 106
- Registration Number
- NCT03012724
- Locations
- 🇺🇸
Kadima Neuropsychiatry, La Jolla, California, United States
🇺🇸CalNeuro Research Group, Los Angeles, California, United States
🇺🇸Advanced Mental Health Care Inc. - Juno Beach, Juno Beach, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- Next